Debrecen, Hungary

Lajos Kun


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lajos Kun: Innovator in Pharmaceutical Processes

Introduction

Lajos Kun is a notable inventor based in Debrecen, Hungary. He has made significant contributions to the pharmaceutical industry, particularly in the development of processes for the preparation of oxytetracycline compounds. With a total of 2 patents, his work has the potential to enhance the efficiency and effectiveness of antibiotic production.

Latest Patents

Lajos Kun's latest patents include a process for the preparation of an oxytetracycline-calcium silicate complex salt. This invention relates to a method for extracting the valuable antibiotic oxytetracycline from fermentation broth in a straightforward manner. The resulting complex can contain up to 50% of the antibiotic, making it suitable for pharmaceutical applications. Additionally, he has developed a process for the preparation of easy-flowing oxytetracyclin hydrochloride. This innovative method transforms needle-shaped crystals into spherical particles, which are more advantageous for pharmaceutical use due to their flowability and purity.

Career Highlights

Lajos Kun is associated with Biogal Gyogyszergyar, a company that specializes in pharmaceutical manufacturing. His work has been instrumental in advancing the production processes of important antibiotics, thereby contributing to public health.

Collaborations

Throughout his career, Lajos has collaborated with notable colleagues such as Miklos Szarvas and Laszlo Cseke. These partnerships have fostered innovation and have played a crucial role in the development of his patented processes.

Conclusion

Lajos Kun's contributions to the field of pharmaceuticals through his innovative processes for oxytetracycline production highlight his importance as an inventor. His work not only enhances the efficiency of antibiotic production but also supports advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…